BioGend Therapeutics Co., Ltd. (6733.TWO)
TWD 28.55
(-9.94%)
TWD 28.55
(-9.94%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -113.1 Million TWD | 29.06% |
| 2022 | -160.62 Million TWD | -38.4% |
| 2021 | -104.71 Million TWD | 8.18% |
| 2020 | -112.15 Million TWD | 15.17% |
| 2019 | -144.79 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.34 Million TWD | 84.58% |
| 2024 Q2 | -27.43 Million TWD | -575.22% |
| 2023 Q4 | -25.86 Million TWD | 23.87% |
| 2023 FY | - TWD | 29.06% |
| 2023 Q3 | -33.97 Million TWD | -225.8% |
| 2023 Q2 | -10.42 Million TWD | 76.13% |
| 2023 Q1 | -43.67 Million TWD | 12.11% |
| 2022 FY | - TWD | -38.4% |
| 2022 Q4 | -49.69 Million TWD | 0.0% |
| 2021 FY | - TWD | 8.18% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -144.585% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 128.736% |
| Level Biotechnology Inc. | 98.7 Million TWD | 214.591% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -152.813% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -56.841% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -348.246% |
| GlycoNex Incorporation | -126.82 Million TWD | 10.819% |
| VBI | -6.97 Million TWD | -1522.289% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 21.287% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 618.597% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -538.08% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -9.16% |
| Visgeneer Inc. | 973 Thousand TWD | 11724.46% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 66.683% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 112.078% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 213.291% |
| Neith Corporation | -33.61 Million TWD | -236.525% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 88.588% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -6411.572% |
| Enimmune corporation | -228.96 Million TWD | 50.601% |
| TaiRx, Inc. | -208.64 Million TWD | 45.79% |
| CHO Pharma, Inc. | -277.73 Million TWD | 59.275% |
| EirGenix Inc. | -664.4 Million TWD | 82.976% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 253.044% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 263.583% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 89.443% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 424.663% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -81.431% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -330.061% |
| RBC Bioscience Corporation | 36.54 Million TWD | 409.481% |
| BiOptic Inc. | 65.03 Million TWD | 273.908% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 83.427% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -242.683% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -105.966% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 126.088% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -41.255% |
| NaviFUS Corp. | -55.79 Million TWD | -102.717% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -581.444% |
| Sinew Pharma Inc. | -163.63 Million TWD | 30.877% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -83.912% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 158.786% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 50.103% |
| AP Biosciences Inc | -325.51 Million TWD | 65.253% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 89.173% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -215.533% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 488.28% |
| Intech Biopharm Corporation | -219.58 Million TWD | 48.491% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 83.224% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -151.621% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 29.685% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 117.254% |
| TCI GENE Inc. | 25.98 Million TWD | 535.341% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -2.231% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 60.144% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 22.514% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 916.65% |
| PharmaEngine, Inc. | 347.3 Million TWD | 132.567% |
| Savior Lifetec Corporation | 219.6 Million TWD | 151.504% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 165.671% |
| OBI Pharma, Inc. | -855.08 Million TWD | 86.773% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -22.194% |
| Acepodia, Inc. | -764.51 Million TWD | 85.206% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 75.417% |